VIZ-CLEAR Linctus

Veritably Clears the Airway

 

COMPOSITION:

Bromhexine HCI IP 4mg+ Dextromethorphan HBr IP 5mg + Chlorpheniramine Maleate IP 2mg + Guaiphenesin IP 50mg+ Menthol IP 1.5mg

Bromhexine HCI

Drug class: Mucolytics

  • Bromhexine is a derivate of the Adhatoda vasica plant for the treatment of various respiratory diseases.
  • It has been found to enhance the secretion of various mucus components by modifying the physicochemical characteristics of mucus.
  • Co-administration of antibiotics with bromhexine amplified the actions of the antibiotic.

Dextromethorphan

VIZ-CLEAR Linctus

Drug class: Antitussive

  • Dextromethorphan is a sigma receptor agonists that has been associated with cough suppression. 
  • It is an antitussive agent for the treatment of dry cough and is devoid of analgesic or addictive property.
  • It readily crosses the blood-brain-barrier activating the sigma opioid receptors in the cough center of the central nervous system, thereby suppressing the cough reflex.

Chlorpheniramine Maleate

Drug class: Antihistamines

  • The FDA-approved antihistamine, Chlorpheniramine Maleate could inhibit influenza virus infection by blocking viral entry into the target cell, the early stage of virus life cycle. 
  • Have demonstrated efficacy against nasal congestion (caused by inflammation, increased nasal secretions) in patients with allergic rhinitis, and the magnitude of benefit is relatively modest.

Guaiphenesin

Drug class: Expectorants

Guaiphenesin

  • Enhances the rate of mucociliary clearance and also demonstrated an expectorant effect in patients with productive coughs. 

Menthol

Drug class: Counterirritant

  • Menthol is an effective antitussive agent in an evoked cough.